Senate2023-24 session

SSB 5300 — Concerning continuity of coverage for prescription drugs prescribed for the treatment of behavioral health conditions.

Signed into law — Chapter 325, Laws of 2023

Sponsor
Dhingra
Introduced
February 9, 2023
Status
C 325 L 23
Last action
Effective date 7/23/2023*. (May 4, 2023)

What this bill does

Prohibits health carriers from requiring substitution of a prescribed nonpreferred drug with a preferred drug or increasing an enrollee’s cost sharing obligation when the prescription is for a refill of an antipsychotic, antidepressant, or antiepileptic drug, or any other drug prescribed to treat a serious mental illness. Adds other drugs prescribed to treat serious mental illness to the drugs for which a pharmacist may not substitute a nonpreferred drug with a preferred drug for state purchased health care programs.

From the Washington State Legislature's nonpartisan staff bill analysis. Read the full analysis ↗

Floor votes

  • House — Final Passage as Amended by the House · April 6, 2023
    98 yea · 0 nay
  • Senate — Final Passage as Amended by the House · April 17, 2023
    48 yea · 0 nay · 1 not voting
  • Senate — 3rd Reading & Final Passage · March 1, 2023
    46 yea · 0 nay · 3 not voting

Track SSB 5300 on OlympiaTrack

A free account adds a plain-English AI summary, the full hearing and amendment record, who testified, and roll calls by member. Plus email alerts when this bill moves.

Create a free account

Other bills sponsored by Dhingra

All 2023-24 Washington State bills →

Source: the Washington State Legislature. OlympiaTrack is an independent bill-tracking service and is not affiliated with the Legislature. View on leg.wa.gov ↗